In NSCLC patient samples, a high p-STAT3 level is associated with advanced disease, smoking, and EGFR status, and can be used as a marker to predict patient survival (Mohrherr et al., 2020). The gene discussed is STAT3; the disease is non-small cell lung carcinoma.